• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Symptom burden in chronic kidney disease; a population based cross sectional study.慢性肾脏病的症状负担:一项基于人群的横断面研究。
BMC Nephrol. 2017 Jul 10;18(1):228. doi: 10.1186/s12882-017-0638-y.
2
Health related quality of life in chronic kidney disease; a descriptive study in a rural Sri Lankan community affected by chronic kidney disease.慢性肾脏病患者的健康相关生活质量:斯里兰卡农村社区慢性肾脏病患者的描述性研究。
Health Qual Life Outcomes. 2020 Apr 23;18(1):106. doi: 10.1186/s12955-020-01369-1.
3
The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients.斯里兰卡中北部慢性肾脏病和病因不明的慢性肾脏病(CKDu)的发病率、患病率和趋势:对 30566 名患者的分析。
BMC Nephrol. 2019 Aug 28;20(1):338. doi: 10.1186/s12882-019-1501-0.
4
Depression and psychological distress in patients with chronic renal failure: Prevalence and associated factors in a rural district in Sri Lanka.慢性肾衰竭患者的抑郁和心理困扰:斯里兰卡一个农村地区的患病率及相关因素。
J Psychosom Res. 2018 Sep;112:25-31. doi: 10.1016/j.jpsychores.2018.06.009. Epub 2018 Jun 18.
5
Quality of Life and Symptom Burden among Chronic Kidney Disease of Uncertain Etiology (CKDu) Patients in Girandurukotte, Sri Lanka.斯里兰卡吉兰杜鲁克特慢性病因不确定的肾病(CKDu)患者的生活质量和症状负担。
Int J Environ Res Public Health. 2020 Jun 5;17(11):4041. doi: 10.3390/ijerph17114041.
6
Symptom Burden and Its Impact on Quality of Life in Patients With Moderate to Severe CKD: The International Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps).中重度慢性肾脏病患者的症状负担及其对生活质量的影响:国际慢性肾脏病结局和实践模式研究(CKDopps)。
Am J Kidney Dis. 2024 Dec;84(6):696-707.e1. doi: 10.1053/j.ajkd.2024.06.011. Epub 2024 Aug 6.
7
Prevalence and risk factors for impaired kidney function in the district of Anuradhapura, Sri Lanka: a cross-sectional population-representative survey in those at risk of chronic kidney disease of unknown aetiology.斯里兰卡阿努拉德普勒地区肾功能受损的患病率和危险因素:在病因不明的慢性肾脏病高危人群中进行的横断面人群代表性调查。
BMC Public Health. 2019 Jun 14;19(1):763. doi: 10.1186/s12889-019-7117-2.
8
Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.法国全国性调查:慢性肾脏病(包括肾衰竭患者)患者的健康感知和生活质量。
Am J Kidney Dis. 2020 Jun;75(6):868-878. doi: 10.1053/j.ajkd.2019.08.026. Epub 2019 Dec 23.
9
WHICH PATIENTS WITH CHRONIC KIDNEY DISEASE HAVE THE GREATEST SYMPTOM BURDEN? A COMPARATIVE STUDY OF ADVANCED CKD STAGE AND DIALYSIS MODALITY.哪些慢性肾脏病患者的症状负担最重?晚期慢性肾脏病阶段与透析方式的比较研究。
J Ren Care. 2016 Jun;42(2):73-82. doi: 10.1111/jorc.12152. Epub 2016 Mar 3.
10
Normality data of eGFR and validity of commonly used screening tests for CKD in an area with endemic CKD of unknown etiology; need for age and sex based precise cutoff values.在一个病因不明的地方性慢性肾脏病流行地区的 eGFR 正常值数据和常用 CKD 筛查试验的有效性;需要基于年龄和性别的精确截断值。
BMC Nephrol. 2019 Aug 5;20(1):298. doi: 10.1186/s12882-019-1477-9.

引用本文的文献

1
Recent advancements in patented technologies for the diagnosis and treatment of chronic kidney disease.慢性肾脏病诊断与治疗专利技术的最新进展。
Int Urol Nephrol. 2025 Apr 11. doi: 10.1007/s11255-025-04501-6.
2
The effectiveness of Melissa officinalis L. essential oil inhalation on anxiety and symptom burden of hemodialysis patients: a randomized trial study.蜜蜂花精油吸入对血液透析患者焦虑及症状负担的有效性:一项随机试验研究。
BMC Complement Med Ther. 2025 Mar 13;25(1):103. doi: 10.1186/s12906-025-04840-y.
3
Health-related quality of life and its predictors among chronic kidney disease patients: A hospital-based cross-sectional study.慢性肾病患者的健康相关生活质量及其预测因素:一项基于医院的横断面研究。
PLoS One. 2025 Feb 7;20(2):e0319100. doi: 10.1371/journal.pone.0319100. eCollection 2025.
4
Clinical and Humanistic Burden of IgA Nephropathy in Adult Patients: A Global Real-World Survey.成年IgA肾病患者的临床及人文负担:一项全球真实世界调查
Kidney360. 2025 Jan 1;6(1):121-132. doi: 10.34067/KID.0000000613. Epub 2024 Oct 22.
5
A Prospective Cohort Study Evaluating Impact of Sarcopenia on Hospitalization in Patients on Continuous Ambulatory Peritoneal Dialysis.一项前瞻性队列研究评估肌少症对持续非卧床腹膜透析患者住院的影响。
Sci Rep. 2024 Jul 23;14(1):16926. doi: 10.1038/s41598-024-65130-0.
6
The trajectory of a range of commonly captured symptoms with standard care in people with kidney failure receiving haemodialysis: consideration for clinical trial design.在接受血液透析的肾衰竭患者中,标准护理下一系列常见症状的轨迹:临床试验设计的考虑。
BMC Nephrol. 2023 Nov 17;24(1):341. doi: 10.1186/s12882-023-03394-w.
7
Digital health interventions in chronic kidney disease: levelling the playing field?慢性肾脏病中的数字健康干预措施:能否创造公平竞争环境?
Clin Kidney J. 2022 Dec 6;16(5):763-767. doi: 10.1093/ckj/sfac259. eCollection 2023 May.
8
Symptom prevalence, severity, distress and management among patients with chronic diseases.慢性病患者的症状患病率、严重程度、痛苦程度及管理情况。
BMC Nurs. 2023 May 6;22(1):155. doi: 10.1186/s12912-023-01296-8.
9
Changes in symptom burden in the first 6 months after dialysis commencement: a prospective longitudinal observational cohort study.透析开始后头6个月症状负担的变化:一项前瞻性纵向观察队列研究。
J Nephrol. 2023 Jun;36(5):1485-1488. doi: 10.1007/s40620-023-01603-1. Epub 2023 Mar 31.
10
Multimorbidity prevalence and patterns in chronic kidney disease: findings from an observational multicentre UK cohort study.慢性肾脏病的多种合并症患病率和模式:来自英国多中心观察队列研究的结果。
Int Urol Nephrol. 2023 Aug;55(8):2047-2057. doi: 10.1007/s11255-023-03516-1. Epub 2023 Feb 21.

本文引用的文献

1
DIFFERENCES IN ILLNESS REPRESENTATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE.慢性肾脏病患者疾病认知的差异
J Ren Care. 2015 Sep;41(3):146-55. doi: 10.1111/jorc.12117. Epub 2015 Mar 5.
2
Chronic kidney disease of unknown etiology in agricultural communities.农业社区中病因不明的慢性肾脏病
MEDICC Rev. 2014 Apr;16(2):9-15. doi: 10.37757/MR2014.V16.N2.3.
3
Symptom burden in chronic kidney disease: a review of recent literature.慢性肾脏病的症状负担:近期文献综述
J Ren Care. 2013 Sep;39(3):140-50. doi: 10.1111/j.1755-6686.2013.12022.x. Epub 2013 Jul 4.
4
Geographical distribution of chronic kidney disease of unknown origin in North Central Region of Sri Lanka.斯里兰卡中北部地区不明原因慢性肾脏病的地理分布
Ceylon Med J. 2013 Mar;58(1):6-10. doi: 10.4038/cmj.v58i1.5356.
5
Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool.了解未接受透析治疗的晚期慢性肾病患者的症状:使用一种简短的患者自评评估工具。
Nephron Clin Pract. 2009;111(1):c74-80. doi: 10.1159/000183177. Epub 2008 Dec 16.
6
Symptoms and their correlates in chronic kidney disease.慢性肾脏病的症状及其相关因素
Adv Chronic Kidney Dis. 2007 Oct;14(4):319-27. doi: 10.1053/j.ackd.2007.07.004.
7
Why illness perceptions matter.为什么疾病认知很重要。
Clin Med (Lond). 2006 Nov-Dec;6(6):536-9. doi: 10.7861/clinmedicine.6-6-536.
8
Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.慢性肾脏疾病作为一个公共卫生问题:流行病学、社会及经济影响
Kidney Int Suppl. 2005 Sep(98):S7-S10. doi: 10.1111/j.1523-1755.2005.09801.x.
9
Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index.慢性血液透析患者症状评估工具的开发:透析症状指数
J Pain Symptom Manage. 2004 Mar;27(3):226-40. doi: 10.1016/j.jpainsymman.2003.07.004.
10
Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale.使用纪念症状评估量表测量临终前重症癌症及非癌症住院患者的症状体验。
J Pain Symptom Manage. 2003 May;25(5):420-9. doi: 10.1016/s0885-3924(03)00074-5.

慢性肾脏病的症状负担:一项基于人群的横断面研究。

Symptom burden in chronic kidney disease; a population based cross sectional study.

作者信息

Senanayake Sameera, Gunawardena Nalika, Palihawadana Paba, Bandara Palitha, Haniffa Rashan, Karunarathna R, Kumara Priyantha

机构信息

Family Health Bureau, Colombo, Sri Lanka.

World Health Organization, Colombo, Sri Lanka.

出版信息

BMC Nephrol. 2017 Jul 10;18(1):228. doi: 10.1186/s12882-017-0638-y.

DOI:10.1186/s12882-017-0638-y
PMID:28693434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5504715/
Abstract

BACKGROUND

Physical and psychological symptoms are among main manifestations of Chronic Kidney Disease (CKD). This study aimed to assess the symptom burden and self-perceived severity of symptoms among CKD patients living in a district in Sri Lanka.

METHOD

A community based cross-sectional study included a sample of randomly selected 1174 CKD patients from all 19 Medical Officer of Health areas in the district of Anuradhapura. Trained para-medical staff visited the households and administered the locally validated questionnaire to assess the presence and severity of symptoms. The inquiry was on 25 symptoms in a 5 point Likert scale indicating the severity during the previous week. Symptom burden score was constructed by summing each symptom severity score which ranged from 0 to 125.

RESULTS

A total of 1118 CKD patients participated with a response rate of 95.2%. The mean age was 58.3 (SD 10.8) years and 62.7% were males. A majority were in CKD stage 4 (58.3%). Bone/joint pain was the most experienced symptom (87.6%; 95%CI 85.6-89.5). Loss of libido was the most severe symptom. The median symptom burden score was 35.0 (IQR 20.0-50.0). Multiple linear regression revealed education up to Advanced Level (β -9.176), CKD stage V (β 3.373), being dialyzed (β 20.944), comorbidities (β 4.241) and being employed (β -9.176) to be significant predictors of symptom burden.

CONCLUSIONS

Patients in all stages of CKD experience high symptom burden warranting rigorous measures to relieve symptoms and to improve the well-being of CKD patients.

摘要

背景

身体和心理症状是慢性肾脏病(CKD)的主要表现之一。本研究旨在评估斯里兰卡某地区CKD患者的症状负担及自我感知的症状严重程度。

方法

一项基于社区的横断面研究,从阿努拉德普勒区的19个卫生医疗官辖区中随机抽取了1174例CKD患者作为样本。经过培训的辅助医务人员走访这些家庭,并使用经过本地验证的问卷来评估症状的存在及严重程度。询问内容涉及25种症状,采用5级李克特量表来表明前一周的症状严重程度。症状负担得分通过将每个症状严重程度得分相加得出,范围为0至125分。

结果

共有1118例CKD患者参与研究,应答率为95.2%。平均年龄为58.3(标准差10.8)岁,男性占62.7%。大多数患者处于CKD 4期(58.3%)。骨/关节疼痛是最常出现的症状(87.6%;95%置信区间85.6 - 89.5)。性欲减退是最严重的症状。症状负担得分的中位数为35.0(四分位间距20.0 - 50.0)。多元线性回归显示,高等教育程度(β -9.176)、CKD 5期(β 3.373)、接受透析治疗(β 20.944)、合并症(β 4.241)以及就业情况(β -9.176)是症状负担的显著预测因素。

结论

CKD各阶段的患者都承受着较高的症状负担,需要采取严格措施来缓解症状并改善CKD患者的健康状况。